Alethea Cope

2.4k total citations
27 papers, 1.7k citations indexed

About

Alethea Cope is a scholar working on Epidemiology, Virology and Infectious Diseases. According to data from OpenAlex, Alethea Cope has authored 27 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Epidemiology, 15 papers in Virology and 6 papers in Infectious Diseases. Recurrent topics in Alethea Cope's work include HIV Research and Treatment (15 papers), Herpesvirus Infections and Treatments (14 papers) and Cytomegalovirus and herpesvirus research (12 papers). Alethea Cope is often cited by papers focused on HIV Research and Treatment (15 papers), Herpesvirus Infections and Treatments (14 papers) and Cytomegalovirus and herpesvirus research (12 papers). Alethea Cope collaborates with scholars based in United Kingdom, United States and France. Alethea Cope's co-authors include Vincent C. Emery, Paul Griffiths, Caroline Sabin, D. Gor, Aycan F. Hassan‐Walker, E Frances Bowen, Andrew K. Burroughs, Keith Rolles, Robin J. Shattock and Martin Cranage and has published in prestigious journals such as The Lancet, The Journal of Experimental Medicine and PLoS ONE.

In The Last Decade

Alethea Cope

27 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alethea Cope United Kingdom	19	1.3k	542	439	404	273	27	1.7k
Carlos López United States	19	901 0.7×	557 1.0×	276 0.6×	328 0.8×	672 2.5×	27	1.9k
Sheena Sutherland United Kingdom	20	965 0.7×	343 0.6×	137 0.3×	264 0.7×	269 1.0×	37	1.5k
Jean‐Marie Huraux France	24	1.5k 1.1×	303 0.6×	243 0.6×	204 0.5×	94 0.3×	46	2.1k
William Buhles United States	23	2.2k 1.7×	521 1.0×	494 1.1×	341 0.8×	225 0.8×	39	2.8k
A. P. Fiddian United Kingdom	21	1.2k 0.9×	423 0.8×	184 0.4×	239 0.6×	131 0.5×	34	1.5k
Bernard Weber Germany	27	1.4k 1.0×	784 1.4×	85 0.2×	507 1.3×	138 0.5×	103	2.2k
H. Clifford Lane United States	18	957 0.7×	414 0.8×	107 0.2×	401 1.0×	244 0.9×	24	1.4k
Jeffrey B. Greene United States	7	810 0.6×	612 1.1×	181 0.4×	348 0.9×	413 1.5×	9	1.5k
David H. Shepp United States	20	1.4k 1.1×	408 0.8×	367 0.8×	332 0.8×	217 0.8×	39	1.8k
Stephen J. Kornfeld United States	11	548 0.4×	283 0.5×	193 0.4×	257 0.6×	629 2.3×	15	1.6k

Countries citing papers authored by Alethea Cope

Since Specialization

Citations

This map shows the geographic impact of Alethea Cope's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alethea Cope with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alethea Cope more than expected).

Fields of papers citing papers by Alethea Cope

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alethea Cope. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alethea Cope. The network helps show where Alethea Cope may publish in the future.

Co-authorship network of co-authors of Alethea Cope

This figure shows the co-authorship network connecting the top 25 collaborators of Alethea Cope. A scholar is included among the top collaborators of Alethea Cope based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alethea Cope. Alethea Cope is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tran, Maxine, Joana B. Neves, Katerina Stamati, et al.. (2019). Acceptability and feasibility study of patient-specific ‘tumouroids’ as personalised treatment screening tools: Protocol for prospective tissue and data collection of participants with confirmed or suspected renal cell carcinoma. PubMed. 14. 24–29. 2 indexed citations

Day, Suzanne, Michael S. Wood, Alethea Cope, et al.. (2019). The Safety and Immunogenicity of GTU®MultiHIV DNA Vaccine Delivered by Transcutaneous and Intramuscular Injection With or Without Electroporation in HIV-1 Positive Subjects on Suppressive ART. Frontiers in Immunology. 10. 2911–2911. 10 indexed citations

Silva, Thushan I. de, Nuredin Mohammed, Alethea Cope, et al.. (2017). Comparison of mucosal lining fluid sampling methods and influenza-specific IgA detection assays for use in human studies of influenza immunity. Journal of Immunological Methods. 449. 1–6. 24 indexed citations

Francis, James N., et al.. (2017). Nasal IgA Provides Protection against Human Influenza Challenge in Volunteers with Low Serum Influenza Antibody Titre. Frontiers in Microbiology. 8. 900–900. 86 indexed citations

Grand, Roger Le, Nathalie Dereuddre‐Bosquet, Stefania Dispinseri, et al.. (2016). Superior Efficacy of a Human Immunodeficiency Virus Vaccine Combined with Antiretroviral Prevention in Simian-Human Immunodeficiency Virus-Challenged Nonhuman Primates. Journal of Virology. 90(11). 5315–5328. 10 indexed citations

Grand, Roger Le, Stefania Dispinseri, Laurent Gosse, et al.. (2014). Microbicide-vaccine Combination Provides Significant Protection against Vaginal SHIV-162P3 Challenge in Cynomolgous Monkeys. AIDS Research and Human Retroviruses. 30(S1). A26–A26. 1 indexed citations

McKay, Paul F., Alethea Cope, Jamie F. S. Mann, et al.. (2014). Glucopyranosyl Lipid A Adjuvant Significantly Enhances HIV Specific T and B Cell Responses Elicited by a DNA-MVA-Protein Vaccine Regimen. PLoS ONE. 9(1). e84707–e84707. 29 indexed citations

Lewis, D. J., Carol Fraser, Rebecca Wiggins, et al.. (2011). Phase I Randomised Clinical Trial of an HIV-1CN54, Clade C, Trimeric Envelope Vaccine Candidate Delivered Vaginally. PLoS ONE. 6(9). e25165–e25165. 40 indexed citations

Cranage, Martin, Carol Fraser, Alethea Cope, et al.. (2010). Antibody responses after intravaginal immunisation with trimeric HIV-1CN54 clade C gp140 in Carbopol gel are augmented by systemic priming or boosting with an adjuvanted formulation. Vaccine. 29(7). 1421–1430. 33 indexed citations

10.

Cranage, Martin, Caroline Fraser, Zoe Stevens, et al.. (2009). Repeated vaginal administration of trimeric HIV-1 clade C gp140 induces serum and mucosal antibody responses. Mucosal Immunology. 3(1). 57–68. 30 indexed citations

11.

Cranage, Martin, Sally Sharpe, Carolina Herrera, et al.. (2008). Prevention of SIV Rectal Transmission and Priming of T Cell Responses in Macaques after Local Pre-exposure Application of Tenofovir Gel. PLoS Medicine. 5(8). e157–e157. 127 indexed citations

12.

Regoes, Roland R., E Frances Bowen, Alethea Cope, et al.. (2006). Modelling cytomegalovirus replication patterns in the human host: factors important for pathogenesis. Proceedings of the Royal Society B Biological Sciences. 273(1596). 1961–1967. 17 indexed citations

13.

Silva, Thushan I. de, Alethea Cope, J R Goepel, & Julia Greig. (2006). The use of adjuvant granulocyte-macrophage colony-stimulating factor in HIV-related disseminated atypical mycobacterial infection. Journal of Infection. 54(4). e207–e210. 18 indexed citations

14.

Bourboulia, Dimitra, John Wilkinson, Peter Hayes, et al.. (2002). Prospective Study of the Effects of Antiretroviral Therapy on Kaposi Sarcoma–Associated Herpesvirus Infection in Patients With and Without Kaposi Sarcoma. JAIDS Journal of Acquired Immune Deficiency Syndromes. 31(4). 384–390. 93 indexed citations

15.

Emery, Vincent C., Alethea Cope, Caroline Sabin, et al.. (2000). Relationship between IgM Antibody to Human Cytomegalovirus, Virus Load, Donor and Recipient Serostatus, and Administration of Methylprednisolone as Risk Factors for Cytomegalovirus Disease after Liver Transplantation. The Journal of Infectious Diseases. 182(6). 1610–1615. 16 indexed citations

16.

Emery, Vincent C., Caroline Sabin, Alethea Cope, et al.. (2000). Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation. The Lancet. 355(9220). 2032–2036. 403 indexed citations

17.

Griffiths, P. D., et al.. (1999). Diagnostic approaches to cytomegalovirus infection in bone marrow and organ transplantation. Transplant Infectious Disease. 1(3). 179–186. 31 indexed citations

18.

Emery, Vincent C., Alethea Cope, E Frances Bowen, D. Gor, & Paul Griffiths. (1999). The Dynamics of Human Cytomegalovirus Replication in Vivo. The Journal of Experimental Medicine. 190(2). 177–182. 193 indexed citations

19.

Griffiths, Paul, Mounir Ait‐Khaled, C P Bearcroft, et al.. (1999). Human herpesviruses 6 and 7 as potential pathogens after liver transplant: Prospective comparison with the effect of cytomegalovirus. Journal of Medical Virology. 59(4). 496–501. 122 indexed citations

20.

Cope, Alethea, Caroline Sabin, Andrew K. Burroughs, et al.. (1997). Interrelationships among Quantity of Human Cytomegalovirus (HCMV) DNA in Blood, Donor‐Recipient Serostatus, and Administration of Methylprednisolone as Risk Factors for HCMV Disease following Liver Transplantation. The Journal of Infectious Diseases. 176(6). 1484–1490. 155 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact